# Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

> clinical trial · VERIFIED · 2026-08-06

Status: RECRUITING · Sponsor: Baptist Health South Florida · Condition: Prostate Cancer

- Company: Baptist Health South Florida
- Sector: diagnostics
- Primary source: https://clinicaltrials.gov/study/NCT07455903

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.
